CBD Chewing Gum: Promising Concept, Thin Evidence
CBD chewing gum drug delivery is a promising concept with limited clinical evidence. Research gaps remain in absorption mechanisms, dosing precision, and long-term safety. Current trials show no significant efficacy over placebo.
Cannabis Oil Did Not Meaningfully Reduce Pain in Nerve-Injury Patients, Rigorous Trial Finds
This cannabis brachial plexus pain RCT found cannabis-based medicine did not improve pain by a clinically important margin. The study advises against adding cannabis oil to standard pain treatment for traumatic brachial plexus injury. Sleep quality…
Expert Commentary on Cannabis Trial for Brachial Plexus Pain
This expert commentary reviews a cannabis brachial plexus neuropathic pain trial showing no significant benefit. The findings help guide clinicians in managing expectations. Continued research into neuropathic pain mechanisms remains essential.
CBD vs Placebo in Fibromyalgia: Clinical Trial Insights
This article reviews the cbd fibromyalgia placebo controlled trial assessing CBD's efficacy against placebo. The trial found no superiority of CBD over placebo in reducing fibromyalgia pain. These findings inform clinicians and patients about CBD's role…
Clinical Evidence on Cannabis Use and Trauma-Focused Treatment for PTSD and Substance Use
Cannabis use and trauma-focused treatment PTSD SUD evidence shows trauma-focused therapies remain effective for PTSD patients using cannabis. This meta-analysis clarifies treatment outcomes for co-occurring PTSD and substance use disorders. Understanding…
Endocannabinoid System Research: Cannabis & PTSD Treatment
This PTSD cannabis trauma meta-analysis examines how cannabis use affects trauma-focused treatments for co-occurring PTSD and substance use disorders. Findings show cannabis does not significantly undermine evidence-based PTSD interventions. This…
Trauma-Focused Treatment and Cannabis Use in PTSD Care
Trauma-focused treatment PTSD cannabis use remains effective even with co-occurring substance use disorders. Cannabis use does not reduce the benefits of trauma-focused psychotherapy. This insight supports maintaining evidence-based PTSD care protocols.